Yun‐Lian Lin

4.9k citations
139 papers · 4.1k indexed · h-index 37

Yun‐Lian Lin

139 papers receiving 4.0k citations

Peers

Yun‐Lian Lin
Comparison fields: 5 of 133
  • Pharmacology 720
  • Complementary and alternative medicine 670
  • Hepatology 364
  • Biochemistry 254
  • Pharmacology 701
Replace Sakae Amagaya with:
Sakae Amagaya Japan
Sang Chan Kim South Korea
Jinlan Zhang China
Chieh‐Fu Chen Taiwan
Tae Cheon Jeong South Korea
Dae Gill Kang South Korea
Ming‐Jiuan Wu Taiwan
Randall J. Ruch United States
Hyung Gyun Kim South Korea
Sung Hwan Ki South Korea
Yun‐Lian Lin relative to Sakae Amagaya Japan Sakae Amagaya's profile →
Citations per field
00.5×2.8×
Sakae Amagaya · 1×
Citations per year

Countries citing papers authored by Yun‐Lian Lin

Since Specialization
Citations

This map shows the geographic impact of Yun‐Lian Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yun‐Lian Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yun‐Lian Lin more than expected).

Fields of papers citing papers by Yun‐Lian Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yun‐Lian Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yun‐Lian Lin. The network helps show where Yun‐Lian Lin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yun‐Lian Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yun‐Lian Lin Line = papers co-authored together Yun‐Lian Lin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202412
2 20232
3 202329
4 20219
5 202114
6 202127
7 201113
8 200911
9 200943
10
Review on Phytochemical Study of Asteraceae in Taiwan (1996~2005)
20087
11 200618
12 200640
13 2005111
14 200540
15 200414
16 20035
17 20031
18 200320
19 20031
20 200210

About Yun‐Lian Lin

Yun‐Lian Lin is a scholar working on Hepatology, Pharmacology and Complementary and alternative medicine, having authored 139 papers that have together received 4.1k indexed citations. Recurring topics across this work include Phytochemistry and Biological Activities (32 papers), Liver physiology and pathology (21 papers), Natural product bioactivities and synthesis (21 papers), Biological and pharmacological studies of plants (13 papers), Drug-Induced Hepatotoxicity and Protection (12 papers), Liver Disease Diagnosis and Treatment (12 papers), Traditional Chinese Medicine Analysis (11 papers) and Bioactive natural compounds (10 papers). The work is most often cited by research in Pharmacology (720 citations), Complementary and alternative medicine (670 citations) and Hepatology (364 citations). Yun‐Lian Lin has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Yueh‐Hsiung Kuo, Yi-Tsau Huang, Wenchang Chiang, Chieh‐Fu Chen, Young‐Ji Shiao, Ming‐Shi Shiao, Chuen‐Neu Wang, Yeh‐Jeng Huang, Cheng-Pei Chung and Yi‐Tsau Huang. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026